ZYBT NASDAQ
Zhengye Biotechnology Holding Limited
1W: -6.9%
1M: -25.1%
3M: +75.3%
YTD: +8.0%
1Y: -49.8%
$1.24
-0.02 (-1.59%)
Weekly Expected Move ±7.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$41M
-14.8% ▼
3Y CAGR: +8.9%
Capital Expenditures
$28M
-139.4% ▼
3Y CAGR: +1.7%
Free Cash Flow
$13M
-63.7% ▼
3Y CAGR: +34.9%
Dividends Paid
$16M
+59.4% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$9M
-149.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | $46M | $56M | $38M | $13M |
| Depreciation & Amort. | $16M | $19M | $24M | $24M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$34M | -$67M | -$20M | -$977K |
| Other Non-Cash Items | $3M | $11M | $6M | $3M |
| Operating Cash Flow | $32M | $17M | $48M | $41M |
| — Investing Activities — | ||||
| Capital Expenditures | -$19M | -$27M | -$7M | -$14M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$1M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | -$7M | $0 | -$3M | -$14M |
| Investing Cash Flow | -$26M | -$27M | -$12M | -$28M |
| — Financing Activities — | ||||
| Net Debt Issuance | $8M | $35M | $25M | -$3M |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | -$11M | -$21M | -$39M | -$16M |
| Other Financing | $0 | $0 | -$4M | -$3M |
| Financing Cash Flow | -$3M | $13M | -$19M | -$22M |
| Net Change in Cash | $2M | $3M | $17M | -$9M |
| Cash End of Period | $6M | $10M | $27M | $19M |
| Free Cash Flow | $5M | -$10M | $37M | $13M |